** = Publications listed in SCI/SSCI/Pubmed
** Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E
mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
Adv Exp Med Biol. 2016; 924:147-155
Doi: 10.1007/978-3-319-42044-8_28
Web of Science
PubMed
FullText
FullText_MUG
** Seles, M; Gutschi, T; Mayrhofer, K; Fischereder, K; Ehrlich, G; Gallé, G; Gutschi, S; Pachernegg, O; Pummer, K; Augustin, H
Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.
BJU Int. 2016; 117(4):592-597
Doi: 10.1111/bju.13108
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun. 2016; 7(15):12008-12008
Doi: 10.1038/ncomms12008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Belic, J; Heitzer, E; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR
Analysis of ctDNA using the mFastSeqS and plasma-Seq methods for screening and therapy monitoring in prostate cancer patients
CLIN CANCER RES. 2016; 22: -Meeting of the American-Association-for-Cancer-Research (AACR) Precision Medicine Series - Integrating Clinical Genomics and Cancer Therapy; JUN 13-16, 2015; Salt Lake, UT.
Doi: 10.1158/1557-3265.PMSCLINGEN15-PR05
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.
Clin Chem. 2015; 61(6):838-849
Doi: 10.1373/clinchem.2014.234286
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ponholzer, A; Trubel, S; Schramek, P; Wimpissinger, F; Feichtinger, H; Springer, C; Wehrberger, C; Fischereder, K; Pummer, K; Martini, T; Mayr, R; Pycha, A; Madersbacher, S
Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional study.
World J Urol. 2014; 32(4):911-916
Doi: 10.1007/s00345-014-1252-2
Web of Science
PubMed
FullText
FullText_MUG
** El-Heliebi, A; Kroneis, T; Zöhrer, E; Haybaeck, J; Fischereder, K; Kampel-Kettner, K; Zigeuner, R; Pock, H; Riedl, R; Stauber, R; Geigl, JB; Huppertz, B; Sedlmayr, P; Lackner, C
Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
J Transl Med. 2013; 11(10):214-214
Doi: 10.1186/1479-5876-11-214
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heitzer, E; Ulz, P; Belic, J; Gutschi, S; Quehenberger, F; Fischereder, K; Benezeder, T; Auer, M; Pischler, C; Mannweiler, S; Pichler, M; Eisner, F; Haeusler, M; Riethdorf, S; Pantel, K; Samonigg, H; Hoefler, G; Augustin, H; Geigl, JB; Speicher, MR
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.
Genome Med. 2013; 5(4):30-30
Doi: 10.1186/gm434
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hoda, MR; Primus, G; Fischereder, K; Von Heyden, B; Mohammed, N; Schmid, N; Moll, V; Hamza, A; Karsch, JJ; Brossner, C; Fornara, P; Bauer, W;
Early results of a European multicentre experience with a new self-anchoring adjustable transobturator system for treatment of stress urinary incontinence in men.
BJU Int. 2013; 111(2):296-303
Doi: 10.1111/j.1464-410X.2012.11482.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hoda, MR; Primus, G; Schumann, A; Fischereder, K; von Heyden, B; Schmid, N; Moll, V; Hamza, A; Karsch, JJ; Steinbach, F; Brössner, C; Bauer, W; Fornara, P
Treatment of stress urinary incontinence after radical prostatectomy: adjustable transobturator male system - results of a multicenter prospective observational study].
Urologe A. 2012; 51(11):1576-1583
Doi: 10.1007/s00120-012-2950-2
Web of Science
PubMed
FullText
FullText_MUG
** Zebisch, A; Staber, PB; Delavar, A; Bodner, C; Hiden, K; Fischereder, K; Janakiraman, M; Linkesch, W; Auner, HW; Emberger, W; Windpassinger, C; Schimek, MG; Hoefler, G; Troppmair, J; Sill, H
Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
Cancer Res. 2006; 66(7):3401-3408
Doi: 10.1158/0008-5472.CAN-05-0115
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Zebisch, A; Staber, PB; Fischereder, K; Bodner, C; Hiden, K; Linkesch, W; Auner, HW; Emberger, W; Windpassinger, C; Schimek, MG; Hoefler, G; Troppmair, J; Sill, H
Two novel activating germline mutations of the C-RAF proto-oncogene predisposing to solid tbmors and therapy-related acute myeloid leukemia.
BLOOD 2004 104: 920A-920A.
Doi: 10.1182/blood.V104.11.3370.3370
Web of Science
FullText
FullText_MUG